Ganirelix Alternatives Compared
Ganirelix | Ethinyl estradiol / levonorgestrel | Ethinyl estradiol / norethindrone |
|
---|
Ganirelix | Ethinyl estradiol / levonorgestrel | Ethinyl estradiol / norethindrone |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Gonadotropin Inhibition. ganirelix may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Endometriosis, Abnormal Uterine Bleeding, Birth Control, Ovarian Cysts, Polycystic Ovary Syndrome, Gonadotropin Inhibition, Emergency Contraception, Premenstrual Syndrome. ethinyl... View more |
Prescription only
Prescribed for Birth Control, Abnormal Uterine Bleeding, Endometriosis, Postmenopausal Symptoms, Acne, Prevention of Osteoporosis, Gonadotropin Inhibition, Menstrual Disorders, Osteoporosis... View more |
Related suggestions Gonadotropin Inhibition
Popular comparisons
|
|||||||||||||||
More about Ganirelix | More about Ethinyl estradiol / levonorgestrel | More about Ethinyl estradiol / norethindrone | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Ethinyl estradiol / levonorgestrel has an average rating of 5.2 out of 10 from a total of 5044 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 41% reported a negative effect. |
Ethinyl estradiol / norethindrone has an average rating of 5.1 out of 10 from a total of 7575 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: ganirelix side effects in more detail. |
See also: ethinyl estradiol / levonorgestrel side effects in more detail. |
See also: ethinyl estradiol / norethindrone side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
|
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Fyremadel | Afirmelle, Altavera, Amethia, Amethia Lo, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Camrese, CamreseLo, Cerinta, Chateal, Chateal EQ, Daysee, Delyla, Dolishale, Elifemme, Enpresse, Falmina, Fayosim, Iclevia, Introvale, Jaimiess, Jolessa, Joyeaux, Kurvelo, Larissia, Lessina, Levlen, Levonest, Levora, Lillow, Lo Simpesse, LoJaimiess, LoSeasonique, Lutera, Marlissa, Minzoya, Myzilra, Orsythia, Portia, Quartette, Rivelsa, Seasonale, Seasonique, Setlakin, Simpesse, Sronyx, Trivora, Twirla, Tyblume, Vienva View more | Alyacen 1/35, Alyacen 7/7/7, Aranelle, Aurovela 1.5/30, Aurovela 1/20, Aurovela 24 Fe, Aurovela Fe 1.5/30, Aurovela Fe 1/20, Balziva, Blisovi 24 Fe, Blisovi Fe 1.5/30, Blisovi Fe 1/20, Brevicon, Briellyn, Chabelina Fe, Charlotte 24 Fe, Cyclafem 0.5/35, Cyclafem 1/35, Cyclafem 7/7/7, Cyonanz, Dasetta, Dasetta 1/35, Dasetta 7/7/7, Estrostep Fe, Femcon Fe, femhrt, Finzala, Fyavolv, Gemmily, Generess Fe, Gildagia, Gildess 1.5/30, Gildess 1/20, Gildess 24 Fe, Gildess Fe 1.5/30, Gildess Fe 1/20, Hailey 1.5/30, Hailey 24 Fe, Hailey Fe 1.5/30, Hailey Fe 1/20, Jinteli, Junel 1.5/30, Junel 1/20, Junel Fe 1.5/30, Junel Fe 1/20, Junel Fe 24, Kaitlib Fe, Larin 1.5/30, Larin 1/20, Larin 24 Fe, Larin Fe 1.5/30, Larin Fe 1/20, Layolis Fe, Leena, Leribane, Lo Loestrin Fe, Loestrin 21 1/20, Lomedia 24 Fe, Melodetta 24 Fe, Merzee, Mibelas 24 Fe, Microgestin 1.5/30, Microgestin 1/20, Microgestin Fe 1.5/30, Microgestin Fe 1/20, Minastrin 24 Fe, Necon 0.5/35, Necon 7/7/7, Nexesta Fe, Norinyl 1+35, Nortrel 0.5/35, Nortrel 1/35, Nortrel 7/7/7, Nylia 1/35, Nylia 7/7/7, Ortho-Novum 7/7/7, Oshih, Philith, Pirmella 1/35, Pirmella 7/7/7, Rhuzdah, Tarina 24 Fe, Tarina Fe 1/20, Taysofy, Taytulla, Tilia Fe, Tri-Legest, Tri-Legest Fe, Vyfemla, Wera, Wymzya Fe, Zenchent, Zenchent Fe View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
16.2 hours |
45 hours |
14 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 8 drugs are known to interact with ganirelix:
|
A total of 457 drugs are known to interact with ethinyl estradiol / levonorgestrel:
|
A total of 458 drugs are known to interact with ethinyl estradiol / norethindrone:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
|
|
|||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
July 21, 1982 |
October 15, 1999 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.